Related references
Note: Only part of the references are listed.Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells
Hisamitsu Ide et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activation
Serge Haan et al.
JOURNAL OF IMMUNOLOGY (2008)
JAK kinases overexpression promotes in vitro cell transformation
L. Knoops et al.
ONCOGENE (2008)
Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity
Megumi Funakoshi-Tago et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining
X. Cynthia Song et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor
Anuradha Pradhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence
Kotaro Shide et al.
LEUKEMIA RESEARCH (2007)
JAK-STAT signaling: From interferons to cytokines
Christian Schindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IL-28 and IL-29: Newcomers to the interferon family
Gilles Uze et al.
BIOCHIMIE (2007)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity
Yoshiyuki Minegishi et al.
IMMUNITY (2006)
Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes
Denise K. Walters et al.
LEUKEMIA RESEARCH (2006)
TYK2 activity promotes ligand-induced IFNAR1 proteolysis
Zrinka Marijanovic et al.
BIOCHEMICAL JOURNAL (2006)
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation
XH Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation - Cross-talk with IGF1 receptor
J Staerk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer
RJ Brown et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Identification of an acquired JAK2 mutation in Polycythemia vera
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphotyrosine proteomic study of interferon α signaling pathway using a combination of immunoprecipitation and immobilized metal affinity chromatography
HY Zheng et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain
RP Donnelly et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression
J Ragimbeau et al.
EMBO JOURNAL (2003)
Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer
N Seubert et al.
MOLECULAR CELL (2003)
The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction
P Saharinen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: Structural implication for Janus kinases
YJ Zhou et al.
MOLECULAR CELL (2001)
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain
SN Constantinescu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation
K Lindauer et al.
PROTEIN ENGINEERING (2001)
A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling
TC Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains
M Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
